MELISSA WHEELER: Open Payments
NPI 1861687386 · WINTER GARDEN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,040 in 146 payments from 20 companies in 2025. Trend: 2023 $1,664 · 2024 $2,716 · 2025 $3,040
Food & beverage: $2,931Education: $110
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $441 |
| ABBVIE INC. | 20 | $377 |
| UCB, Inc. | 17 | $353 |
| Regeneron Healthcare Solutions, Inc. | 9 | $278 |
| Galderma Laboratories, L.P. | 11 | $223 |
| LEO Pharma Inc. | 10 | $220 |
| PFIZER INC. | 17 | $157 |
| MAYNE PHARMA COMMERCIAL LLC | 13 | $156 |
| Lilly USA, LLC | 6 | $142 |
| Amgen Inc. | 6 | $129 |
Products named: TREMFYA, DUPIXENT, Bimzelx, SKYRIZI, NEMLUVIO, ADBRY, CIBINQO, OTEZLA.
Industry payments across FL — which companies pay providers there.
